Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.18K Sell
441
-94
-18% -$1.87K ﹤0.01% 1081
2026
Q1
$10.1K Buy
+535
New +$10K ﹤0.01% 989
2025
Q3
– Sell
-79
Closed -$982 – 1328
2025
Q2
$982 Buy
+79
New +$995 ﹤0.01% 1098
2021
Q3
– Sell
-260
Closed -$4K – 699
2021
Q2
$4K Sell
260
-140
-35% -$2.18K ﹤0.01% 807
2021
Q1
$5K Buy
+400
New +$5.8K ﹤0.01% 629

Other funds holding NOV

CVA Family Office's NOV Position: Q2 2026 in Review

CVA Family Office reduced its NOV (NOV) stake by 18% in Q2 2026, selling an estimated $1.87K and leaving 441 shares worth $8.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

CVA Family Office first reported a position in NOV in Q1 2021 and has held it in 5 quarters since. The position peaked at $10.1K in Q1 2026. 489 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • CVA Family Office held 441 shares of NOV worth $8.18K as of Q2 2026.
  • CVA Family Office sold 94 NOV shares in Q2 2026, an estimated $1.87K.
  • NOV made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1081 holding.
  • CVA Family Office first reported a position in NOV in Q1 2021 and has held it in 5 quarters since.
  • CVA Family Office's NOV position peaked at $10.1K in Q1 2026.
  • 489 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.